Immunic Inc (IMUX)

Jun 12, 2026

IMUX - Finviz

Jun 12, 2026

Jun 12, 2026

Immunic Inc Stock (US45256V1061): Biotech share in focus after recent volatility - AD HOC NEWS

Jun 12, 2026

Jun 11, 2026

Why Did IMUX Stock Surge 33% Pre-Market Today? - Stocktwits

Jun 11, 2026

Jun 10, 2026

Immunic to showcase IMU-856 research at June conferences - Proactive financial news

Jun 10, 2026

Jun 10, 2026

Immunic to Participate in Investor, Industry and Scientific Conferences in June - AD HOC NEWS

Jun 10, 2026

Jun 09, 2026

IMUX Q1 2026 Earnings: Wider-Than-Expected Loss Per Share Amid Pipeline ProgressEarnings Cycle Outlook - newsline.com

Jun 09, 2026

Jun 09, 2026

IMUX Stock Price, Quote & Chart - ChartMill

Jun 09, 2026

Jun 08, 2026

Immunic stock (US45256V1061): Pipeline updates keep investor focus on late-stage catalysts - AD HOC NEWS

Jun 08, 2026

Jun 08, 2026

Immunic Inc. (IMUX) Q1 2026 Earnings: Wider-than-Expected Loss Triggers Sharp SelloffEarnings Sentiment Score - newsline.com

Jun 08, 2026

Jun 04, 2026

Cost of goods sold of Immunic, Inc. – DUS:10V - TradingView

Jun 04, 2026

Jun 02, 2026

IMUX Q1 2026 Earnings: EPS Misses Estimates, Stock Dips 3.24%Final Results - newsline.com

Jun 02, 2026

Jun 01, 2026

IMMUNIC (IMUX) CEO Erik Lundgren files initial Form 3 insider report - Stock Titan

Jun 01, 2026

Jun 01, 2026

MS expert takes the helm - European Biotechnology Magazine

Jun 01, 2026

May 29, 2026

Immunic (IMUX) proxy details 6M-share plan increase and 22.2% dilution - Stock Titan

May 29, 2026

May 29, 2026

Stifel Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $25 - Moomoo

May 29, 2026

May 28, 2026

Immunic to Present Phase 2 CALLIPER Trial Data on Vidofludimus Calcium Impact on Neurofilament Light Chain in Progressive MS at CMSC 2026 - geneonline.com

May 28, 2026

May 28, 2026

Immunic Presents Promising Phase 2 CALLIPER Data for Vidofludimus Calcium in Progressive Multiple Sclerosis, Highlighting Safety, Efficacy, and Novel Disability Assessment Methods 1 - Minichart

May 28, 2026

May 28, 2026

Market movers: Dell, Immunic, Dollar Tree, Synopsys, Best Buy, Giyani Metals... - Proactive financial news

May 28, 2026

May 28, 2026

Immunic presents new vidofludimus calcium data at multiple sclerosis conference - Yahoo! Finance Canada

May 28, 2026

May 28, 2026

Immunic Appoints New CEO to Lead MS Strategy - The Globe and Mail

May 28, 2026

May 28, 2026

Immunic Presents Additional Phase 2 Calliper Trial Data for Vidofludimus Calcium At Cmsc Annual Meeting - marketscreener.com

May 28, 2026

May 28, 2026

Immunic to Present Additional Phase 2 CALLIPER Data Showing Favorable Safety and Disability Signals for Vidofludimus Calcium - TradingView

May 28, 2026

May 28, 2026

New CALLIPER MS data for vidofludimus calcium at CMSC 2026 (IMUX) - Stock Titan

May 28, 2026

May 28, 2026

Progressive MS drug shows similar safety to placebo, no mood worsening 120 weeks - Stock Titan

May 28, 2026

May 28, 2026

Immunic appoints Erik Lundgren as new CEO By Investing.com - Investing.com Australia

May 28, 2026

May 27, 2026

Immunic names Erik Lundgren as CEO; Daniel Vitt steps down - MSN

May 27, 2026

May 27, 2026

Immunic Therapeutics Welcomes New CEO Erik Lundgren - Contract Pharma

May 27, 2026

May 27, 2026

Small cap wrap: Standard Uranium, Blockmate Ventures, Abacus Global, Immunic, Virtuix… - Proactive financial news

May 27, 2026

May 27, 2026

Immunic (IMUX) Appoints Erik Lundgren as New CEO Effective May 2 - GuruFocus

May 27, 2026

May 27, 2026

Immunic stock holds at Buy as Stifel cites new CEO ahead of trial By Investing.com - Investing.com India

May 27, 2026

May 27, 2026

Immunic stock holds at Buy as Stifel cites new CEO ahead of trial - Investing.com Australia

May 27, 2026

May 27, 2026

Immunic, Inc. Announces Chief Executive Officer Changes - marketscreener.com

May 27, 2026

May 27, 2026

Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials - Yahoo Finance

May 27, 2026

May 27, 2026

Immunic lures former Roche exec Erik Lundgren to be its CEO - The Pharma Letter

May 27, 2026

May 27, 2026

Immunic Names Erik Lundgren Chief Executive - Moomoo

May 27, 2026

May 27, 2026

Erik Lundgren becomes Immunic (Nasdaq: IMUX) CEO with milestone-tied pay - Stock Titan

May 27, 2026

May 27, 2026

Immunic appoints Erik Lundgren as new CEO - Investing.com UK

May 27, 2026

May 27, 2026

Press Release: Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer - Moomoo

May 27, 2026

May 27, 2026

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Yahoo Finance

May 27, 2026

May 25, 2026

William Blair Maintains Immunic(IMUX.US) With Buy Rating - Moomoo

May 25, 2026

May 25, 2026

Immunic (IMUX) Surges 6% as Biotech Shares Rebound – Key Levels to WatchInitial Balance - newsline.com

May 25, 2026

May 22, 2026

Wolfe Research initiated coverage on Immunic - Quantisnow

May 22, 2026